| NDC Code | 0078-0371-05 |
|---|
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0371-05) |
|---|
| Product NDC | 0078-0371 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ritalin |
|---|
| Proprietary Name Suffix | La |
|---|
| Non-Proprietary Name | Methylphenidate Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20020605 |
|---|
| End Marketing Date | 20261031 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA021284 |
|---|
| Manufacturer | Novartis Pharmaceuticals Corporation |
|---|
| Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
|---|
| Strength | 30 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE] |
|---|
| DEA Schedule | CII |
|---|